I2Pure
Ashburn, US · Founded 2020 · Delaware corporation
A company whose science team focuses on functional coatings, hybrid nanomaterials, controlled drug release, and bio-based polymer composites for biomedical engineering applications. The page presents only leadership information without detailing the company's specific products.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$300K disclosed across 1 round · 2022
▶$300KraisedDec 2022 · 3 investors · BiotechnologyRule 506(b)
▶$300KraisedDec 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Douglas SpitzExecutive Officer, Director
- Rob PainterExecutive Officer, Director
- Jack KesslerDirector
- Lee LarsonDirector
- Joseph SteinbergDirector
- Offering amount
- $5M
- Amount sold
- $300K
- Minimum investment
- $30K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with I2Pure for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does I2Pure do?
- A company whose science team focuses on functional coatings, hybrid nanomaterials, controlled drug release, and bio-based polymer composites for biomedical engineering applications. The page presents only leadership information without detailing the company's specific products.
- How much funding has I2Pure raised?
- I2Pure has disclosed $300K raised across 1 round.
- Where is I2Pure headquartered?
- I2Pure is headquartered in Ashburn, US.